Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the National Aeronautics and Space Administration, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. Its solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection and automation services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including health information management, managed health, digital transformation, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
Leidos Trading Down 0.2 %
Leidos stock traded down $0.23 during mid-day trading on Tuesday, hitting $98.12. 722,657 shares of the company's stock were exchanged, compared to its average volume of 933,744. The company's 50 day simple moving average is $100.83 and its 200-day simple moving average is $101.07. The firm has a market capitalization of $13.40 billion, a P/E ratio of 19.05, a PEG ratio of 2.28 and a beta of 0.71. The company has a quick ratio of 0.83, a current ratio of 0.90 and a debt-to-equity ratio of 0.99. Leidos has a fifty-two week low of $81.07 and a fifty-two week high of $111.12.
Leidos (NYSE:LDOS - Get Rating) last released its earnings results on Tuesday, August 2nd. The aerospace company reported $1.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.55 by $0.04. The firm had revenue of $3.60 billion during the quarter, compared to analysts' expectations of $3.52 billion. Leidos had a return on equity of 22.18% and a net margin of 5.15%. The company's revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.52 EPS. On average, equities analysts anticipate that Leidos will post 6.37 earnings per share for the current year.
Leidos Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Thursday, September 15th will be issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend is Wednesday, September 14th. Leidos's dividend payout ratio (DPR) is presently 27.96%.
Wall Street Analyst Weigh In
LDOS has been the topic of a number of analyst reports. Truist Financial increased their price target on Leidos from $108.00 to $120.00 in a research note on Wednesday, May 4th. Barclays downgraded Leidos from an "overweight" rating to an "equal weight" rating and set a $105.00 price target on the stock. in a research note on Tuesday, June 7th. Wells Fargo & Company cut their price target on Leidos from $109.00 to $105.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 3rd. The Goldman Sachs Group raised their price objective on Leidos from $118.00 to $132.00 and gave the stock a "buy" rating in a research note on Thursday, April 14th. Finally, StockNews.com raised Leidos from a "hold" rating to a "buy" rating in a research note on Friday, April 15th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $113.00.
Insiders Place Their Bets
In other Leidos news, Director Harry M. Jansen Kraemer, Jr. sold 7,274 shares of the stock in a transaction dated Thursday, May 26th. The stock was sold at an average price of $103.18, for a total transaction of $750,531.32. Following the completion of the transaction, the director now owns 84,277 shares in the company, valued at approximately $8,695,700.86. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Harry M. Jansen Kraemer, Jr. sold 7,274 shares of the firm's stock in a transaction dated Thursday, May 26th. The stock was sold at an average price of $103.18, for a total value of $750,531.32. Following the completion of the transaction, the director now owns 84,277 shares in the company, valued at approximately $8,695,700.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider James Robert Moos sold 516 shares of the firm's stock in a transaction dated Wednesday, June 15th. The shares were sold at an average price of $98.56, for a total value of $50,856.96. Following the completion of the transaction, the insider now owns 21,391 shares of the company's stock, valued at approximately $2,108,296.96. The disclosure for this sale can be found here. Corporate insiders own 1.67% of the company's stock.